SLC35A2 and epilepsy: In the literature, the clinical manifestation of SLC35A2-CDG includes typical neurological symptoms, such as failure to thrive, abnormal brain structures, developmental delay, and epilepsy, but also other clinical features such as muscular hypotonia, skeletal abnormality, facial dysmorphism, or liver defects.